G. Lemm

559 total citations
20 papers, 402 citations indexed

About

G. Lemm is a scholar working on Hematology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, G. Lemm has authored 20 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Immunology. Recurrent topics in G. Lemm's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Hemophilia Treatment and Research (6 papers) and Platelet Disorders and Treatments (4 papers). G. Lemm is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Hemophilia Treatment and Research (6 papers) and Platelet Disorders and Treatments (4 papers). G. Lemm collaborates with scholars based in United States, Germany and United Kingdom. G. Lemm's co-authors include H Warnatz, G. Dolan, Johannes Oldenburg, Rebecca H. Buckley, Harry W. Schroeder, Ricardo U. Sorensen, Melvin Berger, Chaim M. Roifman, Anita Gewurz and Mark Ballow and has published in prestigious journals such as Blood, Neurology and Journal of Thrombosis and Haemostasis.

In The Last Decade

G. Lemm

19 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Lemm United States	9	194	173	68	58	49	20	402
Emmanuelle Bonnin France	7	172 0.9×	257 1.5×	39 0.6×	85 1.5×	151 3.1×	10	477
Rita Michalevicz Israel	14	177 0.9×	163 0.9×	30 0.4×	97 1.7×	29 0.6×	31	422
Anna Poros Hungary	10	142 0.7×	265 1.5×	20 0.3×	46 0.8×	66 1.3×	26	442
C. M. Hurd United Kingdom	12	158 0.8×	189 1.1×	70 1.0×	60 1.0×	88 1.8×	18	432
GR Sutherland Australia	9	87 0.4×	97 0.6×	131 1.9×	93 1.6×	54 1.1×	22	404
Sandra Wymann Switzerland	11	138 0.7×	216 1.2×	40 0.6×	82 1.4×	132 2.7×	20	355
Katsushi Tokunaga Japan	13	63 0.3×	248 1.4×	87 1.3×	75 1.3×	28 0.6×	16	406
H. Asamer Austria	10	76 0.4×	100 0.6×	27 0.4×	84 1.4×	18 0.4×	43	323
J.H.F. Falkenburg Netherlands	7	223 1.1×	249 1.4×	39 0.6×	41 0.7×	15 0.3×	12	404
M Svenson Denmark	9	51 0.3×	236 1.4×	39 0.6×	48 0.8×	118 2.4×	9	398

Countries citing papers authored by G. Lemm

Since Specialization

Citations

This map shows the geographic impact of G. Lemm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Lemm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Lemm more than expected).

Fields of papers citing papers by G. Lemm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Lemm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Lemm. The network helps show where G. Lemm may publish in the future.

Co-authorship network of co-authors of G. Lemm

This figure shows the co-authorship network connecting the top 25 collaborators of G. Lemm. A scholar is included among the top collaborators of G. Lemm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Lemm. G. Lemm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Afonja, Olubunmi, Robert W. Kozak, Paul Petraro, et al.. (2016). Baby hamster kidney cell–derived recombinant factor VIII: a quarter century of learning and clinical experience. Expert Review of Hematology. 9(12). 1151–1164.

Dolan, G., Elisabeth Steinhagen‐Thiessen, Craig M. Kessler, et al.. (2012). Advances in Hemophilia Care: Report of Two Symposia at the Hemophilia 2010 World Congress. Advances in Therapy. 29(S1). 1–16. 2 indexed citations

Mahlangu, Johnny, Michael Laffan, Jerzy Windyga, et al.. (2012). Phase I, randomized, double‐blind, placebo‐controlled, single‐dose escalation study of the recombinant factor VIIa variant BAY 86‐6150 in hemophilia. Journal of Thrombosis and Haemostasis. 10(5). 773–780. 29 indexed citations

Apeler, Heiner, Jörg Peters, Werner Schröder, et al.. (2011). Expression, Purification, Biochemical and Pharmacological Characterization of a Recombinant Aprotinin Variant. Arzneimittelforschung. 54(8). 483–497. 3 indexed citations

Mahlangu, Johnny, Michael Laffan, Jerzy Windyga, et al.. (2010). Phase I, Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Study of the rFVIIa Variant (BAY 86–6150) In Hemophilia A or B with or without Inhibitors.. Blood. 116(21). 3679–3679. 4 indexed citations

Oldenburg, Johannes, G. Dolan, & G. Lemm. (2008). Haemophilia care then, now and in the future. Haemophilia. 15(s1). 2–7. 55 indexed citations

Collins, Peter W., A. Faradji, Massimo Morfini, et al.. (2008). Efficacy and Safety of Secondary Prophylactic Versus On-Demand Sucrose-Formulated Recombinant Factor VIII Treatment in Adults with Severe Hemophilia A: Results from a 13-Month Crossover Study. Blood. 112(11). 516–516. 3 indexed citations

Roifman, Chaim M., Harry W. Schroeder, Melvin Berger, et al.. (2003). Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. International Immunopharmacology. 3(9). 1325–1333. 104 indexed citations

Lemm, G.. (2002). Composition and properties of IVIg preparations that affect tolerability and therapeutic efficacy. Neurology. 59(12_suppl_6). S28–32. 48 indexed citations

10.

Lemm, G., J. Küppers, R Frey, W. Wingender, & J. Kuhlmann. (1998). Monitoring of proteinuria in phase I studies in healthy male subjects. European Journal of Clinical Pharmacology. 54(4). 287–294. 5 indexed citations

11.

Warnatz, H, et al.. (1990). [Interleukin-1 in the pathogenesis of chronic polyarthritis].. PubMed. 85(5). 302–7. 5 indexed citations

12.

Lemm, G., et al.. (1989). Spontaneous and LPS-stimulated production of intracellular IL-1 beta by synovial macrophages in rheumatoid arthritis is inhibited by IFN-gamma.. PubMed. 76(2). 246–51. 26 indexed citations

13.

Lemm, G., et al.. (1988). INTERLEUKIN-2 SECRETION BY SYNOVIAL FLUID LYMPHOCYTES IN RHEUMATOID ARTHRITIS. Lara D. Veeken. 27(5). 350–356. 8 indexed citations

14.

Lemm, G., et al.. (1988). An ELISA for IgA- IgG and IgM-RF Measurement. II. RF in Several Disease and Control Groups and under Gold Therapy in RA. Scandinavian Journal of Rheumatology. 17(sup75). 256–260. 6 indexed citations

15.

Lemm, G., et al.. (1988). An ELISA for IgA, IgG and IgM-RF Measurement. I. Parameters of the Assay. Scandinavian Journal of Rheumatology. 17(sup75). 32–35. 1 indexed citations

16.

Lemm, G. & H Warnatz. (1986). Evidence for enhanced interleukin 2 (IL-2) secretion and IL-2 receptor presentation by synovial fluid lymphocytes in rheumatoid arthritis.. PubMed. 64(1). 71–9. 45 indexed citations

17.

Lemm, G. & H Warnatz. (1984). Enumeration of T cell subsets and functional suppressor cell assays in patients with rheumatoid arthritis and HLA-B27-associated arthritis.. PubMed. 43(3). 106–12. 3 indexed citations

18.

Lemm, G., et al.. (1984). [A solid-phase ELISA with specificity for rheumatoid factors of classes IgA, IgG and IgM].. PubMed. 12(5). 239–44. 3 indexed citations

19.

Lemm, G., et al.. (1983). Studies on immunoregulatory mechanisms in acute and chronic hepatitis B.. PubMed. 52(2). 250–8. 23 indexed citations

20.

Amrhein, Nikolaus, et al.. (1983). Inhibition of lignin formation by L-alpha-aminooxy-beta-phenylpropionic acid, an inhibitor of phenylalanine ammonia-lyase.. PubMed. 29(2). 139–44. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact